India vs Myanmar: Hypertension effective treatment coverage (controlled hypertension)
India
14.8%
in 2019
Myanmar
15.0%
in 2019
India rank
112th
Myanmar rank
110th
Hypertension effective treatment coverage (controlled hypertension) over time
- India
- Myanmar
How they compare
Myanmar currently reports 15.0% against 14.8% in India, a difference of 0.2%.
Across all 30 years both countries report, Myanmar has been ahead every year.
India ranks 112th and Myanmar ranks 110th of 193 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2.0% | 4.2% | 2.1% | Myanmar |
| 2000s | 5.2% | 7.8% | 2.6% | Myanmar |
| 2010s | 11.2% | 13.1% | 1.9% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), India or Myanmar?
- Myanmar, at 15.0% against 14.8% in India as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between India and Myanmar?
- 0.2%, with Myanmar ahead.
- How many years of comparable data are there for India and Myanmar?
- 30 years are reported by both, from 1990 to 2019.
- How do India and Myanmar rank globally for hypertension effective treatment coverage (controlled hypertension)?
- India ranks 112th and Myanmar ranks 110th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.